Blood clot risk study for brain tumor patients
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at blood clotting risks in people having surgery for meningioma or glioma brain tumors, and compares them to healthy volunteers. It may help doctors better understand and prevent blood clots after brain tumor surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for surgery to remove a meningioma or glioma brain tumor
- Or you are a healthy volunteer without a brain tumor
- You are willing to give written consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a special blood test (called thromboelastography) that checks how well your blood clots. The goal is to see if this test can predict how the surgery goes and whether you might get a blood clot after surgery. If you join, the test will be done before and after your brain surgery, and you will be monitored for any blood clot complications.
This study looks at how blood “platelets” may be involved in brain or spinal (medullary) tumors by testing tumor tissue taken during surgery or biopsy. It may help researchers understand disease biology and guide future treatments.
This study looks at how the brain's protective barrier works in people with glioblastoma. Researchers will study tumor tissue and use special scans to learn more, which might help improve future treatments.
This study looks at the blood clots removed from the brain during a procedure called thrombectomy. By studying them, researchers hope to learn more about how to treat strokes and what causes them, which could help improve care.
This study looks at how blood flow in the brain changes when there is a mass that can be removed with surgery. You would join before any treatment, which helps doctors understand the link between the brain lesion and blood vessel function.
This trial tests whether apixaban, a blood thinner, can prevent dangerous blood clots in people with a certain type of malignant brain tumor who are getting radiation and chemotherapy. It may help lower the risk of clots like leg clots or lung clots.
Hear when a new Surgical Resection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.